Event Watch: Runway for Hope 2024

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12CMutated Metastatic Colorectal Cancer

A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors

A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma

A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors

Mary Crowley Featured on My Sweet Charity Blog

Mary Crowley Ranked #1 Phase I Oncology Site by Vial.com

Event Watch: Pushing Hope

Mary Crowley Receives $50,000 from Fichtenbaum Trust Grant

Ethnically and Language Concordant Clinical Trial Educational Intervention to Increase Diversity in Cancer Clinical Trial Participation